5 Year Evolution of PCI vs CABG in Large Randomized Studies on Acute and Chronic Coronary Syndrome

Left main lesions in acute coronary syndrome (ACS) represent a major risk and, at present, the best revascularization strategy is a matter of debate. Though many studies and registries have excluded this group of patients, there is data on the pros and cons of both percutaneous coronary intervention (PCI) and cardiac artery bypass graft (CABG). 

Evolución a 5 años de la angioplastia vs cirugía en los grandes estudios sobre síndromes agudos y crónicos

This analysis looked at 4 randomized studies comparing PCI with drug eluting stents (DES) vs. CABG (SYNTAX, PRECOMBAT, NOBLE and EXCEL) including a total of 1,466 patients (33.4%) with SCA and 2,927 without SCA (NSCA).

Primary end point was all cause mortality at 5 years. Mean age was 65 and most patients were men. There were no significant differences between the groups, except for a higher prevalence of diabetes, prior MI, ejection fraction <50 and higher SYNTAX score, among SCA patients (26.4 vs. 25.2; p < 0.001).

Time from randomization to procedure was shorter in patients undergoing PCI.

At 30 days, there was higher cardiovascular and non-cardiovascular mortality in SCA patients vs. NACS (1.8 vs. 0.5 p<0.001 AND 1.9 vs. 0.5 p<0.001 respectively).

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Read also: Minimal Stent Area: New IVUS Parameter?

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Primary end point resulted similar with PCI for both ACS and NACS patients (10.9% vs 11.5% HR, 0.93; 95% CI, 0.68-1.27 and 11.3%vs 9.6% HR, 1.19; 95% CI, 0.95-1.50 respectively). There was a lower rate of stroke in the PCI group, but this group also showed higher need for repeat revascularization or MI vs. CABG patients. 

Conclusion

Among patients undergoing left main revascularization with low to intermediate coronary anatomical complexity, patients presenting ACS had a higher rate of early mortality. However, 5-year mortality was similar between PCI and CABG. In the short term, PCI had a relative advantage over CABG in terms of stroke. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes. A Pooled Analysis of 4 Randomized Clinical Trials

Reference: Prakriti Gaba, et al. JAMA Cardiol. doi:10.1001/jamacardio.2023.1177.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...